viewProactive Australia

Atlas Iron is the ASX Most Active intra-day as share price plummets

Atlas Iron has traded around $7 million worth of stock by 12 noon.

Trading is frantic in the small caps today

Atlas Iron Ltd's (ASX:AGO) shares are sinking fast on the ASX today, down 18.8% to 3.6 cents at midday.

Over 180 million shares have changed hands already.

Atlas had recently been delivering a share price renaissance, touching a 12-month high earlier in the week of 4.6 cents.

That has abruptly come to a halt following a North West Infrastructure (NWI) update.

Atlas received notice from the office of the Minister for Transport, Planning and Lands that implies that NWI does not have a priority right to develop Stanley Point Berths 3 and 4 in the Port of Port Hedland, Western Australia.

The Minister has confirmed that Stanley Point Berths 3 and 4 are set aside for junior miners.

The Minister advises that the Pilbara Ports Authority will assess any application by NWI to develop these berths on its merits in accordance with the Pilbara Ports Authority’s standard port development processes.

Atlas said that it considers that this position is contrary to the previous stated policy of the Western Australian government and is considering its position with respect to this notice.

In 2009 NWI was conferred a 50mtpa channel capacity allocation to facilitate the development of a stockyard and two berth facility in Stanley Point.

ASX Most Traded at midday

Company Name Code Last Change Volume
Atlas Iron Ltd AGO $0.036 -18.18 181,395,714
Jacka Resources Ltd JKA $0.002 0.00 33,398,620
White Cliff Minerals Ltd WCN $0.002 0.00 31,500,000
SmartTrans Holdings Ltd SMA $0.004 0.00 25,980,290
Hardey Resources Ltd HDY $0.004 0.00 25,356,071
Paladin Energy Ltd PDN $0.190 5.56 23,649,844
Telstra Corporation Ltd TLS $2.845 3.08 20,121,840
Lakes Oil NL LKO $0.002 0.00 18,755,878
Jacka Resources Ltd JKAOC $0.001 0.00 17,850,000
Genetic Technologies GTG $0.009 0.00 15,854,091

Quick facts: Proactive Australia

Price: - -

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



CytoDyn continues to works on licensing deals as FDA continues its review on...

CytoDyn (OTCQB: CYDY) President and Chief Executive Officer Nader Pourhassan joined Steve Darling from Proactive to discuss a number of issues including the very latest on their clinical trials for a COVID-19 treatment. Pourhassan also told Proactive that they are in discussions with numerous...

40 minutes ago

2 min read